Screening for Hepatocellular Carcinoma in Chronic Carriers of Hepatitis B and C in Markazi Province, Iran


Ali Fani 1 , * , Iman Fani 2 , Babak Eshrati 3 , Parivash Samadian 3 , Parisa Fani 3 , Yaser Gorishi 3 , Fatemeh Mahdaviani 3

1 Department of Internal Medicine, Arak University of Medical Sciences (AUMS) & Department of Internal Medicine, Vali-e-Asr Hospital, Arak University of Medical Sciences (AUMS), [email protected], IR-IRan

2 Department of Radiology, Isfahan University of Medical Sciences, IR-Iran

3 Department of Epidemiology & Biostatistics, Arak University of Medical Sciences (AUMS), IR-Iran

How to Cite: Fani A, Fani I, Eshrati B, Samadian P, Fani P, et al. Screening for Hepatocellular Carcinoma in Chronic Carriers of Hepatitis B and C in Markazi Province, Iran, Hepat Mon. Online ahead of Print ; 7(3):149-152.


Hepatitis Monthly: 7 (3); 149-152
Article Type: Research Article
Received: June 16, 2007
Accepted: October 4, 2007


Background and Aims: Chronic HBV and HCV infections are known as important underlying causes of hepatocellular carcinoma (HCC). Their prevalence in Iran are estimated to be 1.7-5% and 0.5-1%, respectively. We investigated the prevalence of HCC in chronic carriers of HBV and HCV via alpha-feto protein (AFP) measurement and ultrasonography as well as pathological assessments.
Methods: In this cross-sectional study, HBV and HCV positive cases were determined from documents in blood banks since 1985. From 1064 aviable cases, 514 were randomly selected and followed up for two consecutive years. For all patients, AFP testing and sonography were done after reconfirmation of chronicity. Cases with nodules or mass in sonography and AFP levels above 20 ng/ml were considered suspicious for HCC and after rechecking were referred for liver biopsy. Finally, HCC was confirmed pathologically.
Results: The mean subjects' age was 35.19±13.16 years and hepatitis duration was 6.12±5.66 years. Twenty-nine (5.7%) had elevated AFP and 18 (3.5%) had nodules in sonogram. In 16 (3.13%) cases, HCC was detected pathologically. Risk of HCC was correlated with age >40 years, cirrhosis and hepatitis duration (P<0.001). There was no correlation between the risk of HCC and the type of hepatitis, HBeAg positivity, sex and ALT levels.
Conclusions: Early screening for HCC using AFP and sonography can be useful for HCC detection in HCV and HBV chronic carriers.

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF